English | Español

Pharmaceuticals

+ Pharmaceuticals
Patient Daily | Jun 2, 2026

Merck’s TROP2 strategy draws attention at ASCO as Keytruda faces future competition
+ Pharmaceuticals
Patient Daily | Jun 2, 2026

Moderna and Merck report improved survival with mRNA melanoma vaccine at ASCO meeting
+ Pharmaceuticals
Patient Daily | Jun 2, 2026

FDA advisory committee to review Moderna mRNA flu vaccine in June
+ Pharmaceuticals
Patient Daily | Jun 2, 2026

Pfizer presents new cancer drug data at ASCO, with key results still pending
+ Pharmaceuticals
Patient Daily | Jun 1, 2026

FARE to lead national conversation on food allergy at Menus of Change Summit
+ Pharmaceuticals
Patient Daily | Jun 1, 2026

Immuneering’s pancreatic cancer drug shows extended survival in Phase 2a trial
+ Pharmaceuticals
Patient Daily | Jun 1, 2026

Brain surgery at Northwestern Medicine helps Illinois woman overcome infertility
+ Pharmaceuticals
Patient Daily | May 31, 2026

Roswell Park scientists to present five cancer studies at ASCO annual meeting

Trending
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. Y. Bailey | Aug 7, 2026

PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'
Patient Daily reports | Aug 10, 2026

SoCal Breathe Free warns persistent sinus symptoms may signal chronic inflammation
+ Pharmaceuticals
Patient Daily | Aug 7, 2026

Researchers develop computer model linking brain chemistry to neural activity patterns